Cardiology
News
First risk score to predict bleeding risk after TAVR
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
SHM Converge
Medication in heart failure: Pro tips on therapy with the ‘four pillars of survival’
Consider multiple factors when titrating various medications.
SHM Converge
In-hospital resuscitation: Focus on effective chest pumps, prompt shocks
Consider mechanical piston compressions and even “reverse CPR” when appropriate.
News
Subclinical myocarditis found in some athletes post COVID
A study that evaluated college athletes recently infected with COVID-19 with comprehensive cardiac testing, including MRI, found a small...
News
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase...
Clinical
Significant reduction of alcohol intake reduced AFib burden and recurrence
In patients with symptomatic paroxysmal or persistent AFib who report alcohol consumption of 10 or more standard drinks per week, how does...
News
New AHA/ASA guideline on secondary stroke prevention
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in...
News
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
As CDC investigates rare, mostly mild cases of myocarditis in adolescents and young adults given the Pfizer or Moderna vaccine, AHA emphasizes...
News
GALACTIC-HF: Novel drug most effective in sickest HFrEF patients
In GALACTIC-HF trial, the greatest relative benefit of omecamtiv mecarbil was in the sickest HFrEF patients.
News
Sotagliflozin’s HFpEF benefit confirmed by new analyses